Thermostable FGF-1 Variants for Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing human pluripotent stem cells require high concentrations of FGF-2, which are costly and inefficient, and FGF-1 does not support pluripotency despite targeting the same receptors, due to instability and unclear functional differences among FGF proteins.
Innovation Solution
Development of thermostable FGF-1 variants with amino acid substitutions at positions 40, 47, and 93, and optionally in the heparin binding domain, which are more stable and effective in supporting pluripotency and differentiation of human pluripotent stem cells at lower concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high concentrations of FGF-2 are used to culture human pluripotent stem cells, then pluripotency maintenance is improved, but culture cost increases and efficiency decreases
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of FGF-1 at specific positions (40, 47, and 93) to create thermostable variants. This structural parameter change enhances protein stability and activity, allowing effective pluripotency maintenance at lower concentrations (10-100 ng/mL) compared to conventional FGF-2 requirements, thereby reducing culture cost while maintaining reliability
Solution Approach 2:
The patent creates engineered copies of FGF-1 with modified amino acid sequences that replicate and enhance the desired functions of FGF-2. These copied variants (e.g., FGF-1 Q40P/S47I/H93G) are designed to bind FGF receptors more effectively, achieving comparable or superior pluripotency maintenance at reduced concentrations, thus improving efficiency and reducing substance quantity required
2Quantity of substance
If FGF-1 is used instead of FGF-2, then cost may be reduced, but protein stability and functional effectiveness worsen
Solution Approach 1:
The patent fundamentally changes the stability parameter of FGF-1 by introducing specific amino acid substitutions at positions 40, 47, and 93. These parameter changes in the protein structure confer thermostability and enhanced resistance to proteolytic degradation, transforming FGF-1 from an unstable protein into a stable alternative that maintains effectiveness throughout culture periods without requiring high concentrations or frequent medium changes
3Device complexity
If conventional FGF-1 is used, then amino acid sequence simplicity is maintained, but functional effectiveness in supporting pluripotency decreases
Solution Approach 1:
The patent applies local quality by making targeted amino acid substitutions at specific positions (40, 47, and 93) within the FGF-1 sequence rather than altering the entire protein. This localized modification approach maintains overall sequence simplicity and structural integrity while conferring enhanced thermostability and receptor binding affinity, thereby improving pluripotency support capability without excessive complexity
Solution Approach 2:
The patent changes specific parameters of the amino acid sequence at key positions to optimize function. The substitutions at positions 40, 47, and 93 are carefully selected to enhance stability and activity parameters while minimizing overall sequence complexity, achieving improved reliability with controlled complexity increase
Data Source
AI summary
Methods are provided that exploit thermostable FGF-1 proteins for support of human pluripotent stem cell cultures. Also provided are compositions containing thermostable FGF-1 for culturing of human pluripotent stem cells.